Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival

被引:10
|
作者
Wohnrath, Durval R. [1 ]
Araujo, Raphael L. C. [1 ,2 ,3 ,4 ]
机构
[1] Barretos Canc Hosp, Dept Upper Gastrointestinal & Hepato Pancreto Bil, Barretos, SP, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Digest Surg, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil
[3] United Hlth Grp, Amer Med Serv Brazil, Dept Oncol, Sao Paulo, SP, Brazil
[4] Hosp Israelita Albert Einstein, Dept Oncol, Sao Paulo, SP, Brazil
关键词
gastric cancer; lymphadenectomy; oncologic outcomes; surgery; survival; EXAMINED LYMPH-NODES; PARAAORTIC LYMPHADENECTOMY; SELECTING PATIENTS; N-RATIO; DISSECTION; D2; CHEMORADIOTHERAPY; ADENOCARCINOMA; SUPERIORITY; SURGERY;
D O I
10.1002/jso.25755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionThis study addressed whether the positive node-ratio (N-ratio) for patients who underwent curative-intent treatment was an independent prognostic factor of overall survival (OS) for gastric adenocarcinoma (GA). MethodsConsecutive patients who underwent gastrectomy for GA with at least 15 harvested nodes were evaluated for 5-year OS. The best threshold was determined using the area under an receiver operating characteristic (ROC) curve. Univariate and multivariate models were assessed looking for independent prognostic factors for OS. ResultsFrom 1994 to 2015, 398 consecutive patients were evaluated. The N-ratio >= 11% had an accuracy of 0.764, the sensitivity of 71.1%, the specificity of 81.7%, positive predictive value (PPV) of 91.7%, and odds ratio (OR) of 11. After multivariate analysis for OS, age >= 70 years (HR 1.44), need for total gastrectomy (HR 1.45), need for extended resection (HR 1.7), and N-ratio >= 11% (HR 3.7) were unfavorable prognostic factors. D2 lymphadenectomy (HR 0.53) was a protective factor. The median OS according to N-ratio was 14 months for N-ratio >11 vs 58 months for N-ratio <11%. ConclusionThe N-ratio >= 11% was an independent negative prognostic factor for patients who underwent treatment for GA with curative intent. The N-ratio >= 11% presented high specificity, high PPV and high OR for risk of death for 5 years after surgery.
引用
收藏
页码:777 / 783
页数:7
相关论文
共 50 条
  • [21] Neural Invasion is an Independent Prognostic Factor in Young and Lymph Node Negative Gastric Cancer Patients Underwent Curative Gastrectomy
    Wang, Linjun
    Xia, Yiwen
    Jiang, Tianlu
    Li, Ying
    Shen, Yikai
    Lin, Jie
    Li, Fengyuan
    Wang, Weizhi
    Zhang, Diancai
    Xu, Hao
    Yang, Li
    Xu, Zekuan
    JOURNAL OF INVESTIGATIVE SURGERY, 2023, 36 (01)
  • [22] The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients with Gastric Adenocarcinoma
    Ramos-Esquivel, A.
    Cordero-Garcia, E.
    Brenes-Redondo, D.
    Alpizar-Alpizar, W.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 728 - 734
  • [23] The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients with Gastric Adenocarcinoma
    A. Ramos-Esquivel
    E. Cordero-García
    D. Brenes-Redondo
    W. Alpízar-Alpízar
    Journal of Gastrointestinal Cancer, 2019, 50 : 728 - 734
  • [24] Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer
    Wang, Huan
    Xing, Xiao-Ming
    Ma, Lei-Na
    Liu, Lian
    Hao, Jing
    Feng, Ling-Xin
    Yu, Zhuang
    ONCOLOGY LETTERS, 2018, 15 (06) : 8853 - 8862
  • [25] Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer
    Kim, Jeong Hwan
    Han, Dong-Seok
    Bang, Ho Yoon
    Kim, Pyeong Su
    Lee, Kyung-Yung
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2015, 89 (02) : 81 - 86
  • [26] The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy
    Aoyama, Toru
    Yamamoto, Naoto
    Kamiya, Mariko
    Murakawa, Masaaki
    Tamagawa, Hiroshi
    Sawazaki, Sho
    Numata, Masakatsu
    Shiozawa, Manabu
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Yukawa, Norio
    Oshima, Takashi
    Yoshikawa, Takaki
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    ANTICANCER RESEARCH, 2018, 38 (08) : 4877 - 4882
  • [27] The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer
    He, Min
    Zhang, Jia-Xin
    Jiang, Yi-Zhou
    Chen, Ying-Le
    Yang, Hai-Yuan
    Tang, Li-Chen
    Shao, Zhi-Ming
    Di, Gen-Hong
    ONCOTARGET, 2017, 8 (27) : 44870 - 44880
  • [28] Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer
    Hatoum, Hassan A.
    Jamali, Faek R.
    El-Saghir, Nagi S.
    Musallam, Khaled M.
    Seoud, Muhieddine
    Dimassi, Hani
    Abbas, Jaber
    Khalife, Mohamad
    Boulos, Fouad I.
    Tawil, Ayman N.
    Geara, Fadi B.
    Salem, Ziad
    Shamseddine, Achraf A.
    Al-Feghali, Karine
    Shamseddine, Ali I.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3388 - 3395
  • [29] The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
    Aoyama, Toru
    Maezawa, Yukio
    Hashimoto, Itaru
    Yamamoto, Sosuke
    Esashi, Ryuki
    Hara, Kentaro
    Tamagawa, Ayako
    Cho, Haruhiko
    Tanabe, Mie
    Morita, Junya
    Kazama, Keisuke
    Numata, Masakatsu
    Kawahara, Shinnosuke
    Oshima, Takashi
    Saito, Aya
    Yukawa, Norio
    IN VIVO, 2024, 38 (04): : 2001 - 2008
  • [30] Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment
    Aoyama, Toru
    Kato, Aya
    Maezawa, Yukio
    Hashimoto, Itaru
    Hara, Kentaro
    Komori, Keisuke
    Kawahara, Shinnosuke
    Numata, Masakatsu
    Kazama, Keisuke
    Sawazaki, Sho
    Kamiya, Natsumi
    Yoshizawa, Suzue
    Otani, Kazuki
    Tamagawa, Ayako
    Cho, Haruhiko
    Tamagawa, Hiroshi
    Oshima, Takashi
    Yukawa, Norio
    Saito, Aya
    Rino, Yasushi
    ANTICANCER RESEARCH, 2024, 44 (01) : 339 - 346